Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers from Department of Experimental Psychology have found that, during lockdown, teenagers mental health is struggling compared to their parents.

School bag and equipment next to a face mask

The Oxford ARC study, launched in May, has found that teenagers consistently report higher levels of anxiety and depression than parents. Around 35% of teenagers are saying they feel lonely often or most of the time, compared to 17% of parents. At the same time, about 40% of parents say they never feel lonely, compared to only 20% of teenagers. Since May, teenagers consistently reported that they felt unable to control the important things in life, with rates as high as 60% last month.

Now, millions of teenagers are returning to school. Far from being a typical return to school after summer break, this year’s students will bring with them unique experiences, worries, and traumas from lockdown during this global pandemic lockdown.

The Oxford ARC study, is launching a new phase of research in order to understand how certain aspects of the school experience are helping or harming young people’s mental health during the transition back to school and into the ‘new normal’. Teenagers interested in taking part can go to the Oxford ARC website to find out more.

The full story is available on the University of Oxford website

This story is also discussed in a Department of Experimental Psychology blog

Similar stories

New form of gift wrap drives male reproductive success

General Research

A study from the Department of Physiology, Anatomy and Genetics (DPAG) has identified a new communication mechanism that ensures the transfer of a complex mix of signals and nutrients required for successful reproduction between males and females.

PRINCIPLE trial finds antibiotics azithromycin and doxycycline not generally effective treatments for COVID-19

Coronavirus COVID-19 General Research

In March 2020, the UK-wide Platform Randomised trial of INterventions against COVID-19 In older people (PRINCIPLE) trial was established as a flexible, platform randomised clinical trial to test a range of potential treatments for COVID-19 that might be suitable for use in the community to help people recover more quickly and prevent the need for hospital admission. The trial is one of three national platform trials for COVID-19 treatments, and complements the RECOVERY and REMAP-CAP trials that focus on hospitalised patients.

Early animal studies yield promising results for new potential COVID-19 vaccine

Coronavirus COVID-19 General Research

Studies carried out in the MRC Human Immunology Unit (MRC HIU) in collaboration with the Pirbright Institute have shown that a new potential vaccine against COVID-19, named RBD-SpyVLP, produces a strong antibody response in mice and pigs, providing vital information for the further development of the vaccine. Although this type of vaccine is not a competitor for the first wave of vaccines, it is hoped that it will be useful as a standalone vaccine or as a booster for individuals primed with a different COVID-19 vaccine.

Just over half of British Indians would take COVID vaccine

Coronavirus COVID-19 General Research

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

General Innovation Research

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.